Figures
Abstract
Purpose
The purpose of this study was to examine the ocular and systemic risk profile of the fundus phenotype ≥ 20 small hard (macular) drusen (< 63 μm in diameter).
Methods
This single-center, cross-sectional study of 176 same-sex twin pairs aged 30 to 80 (median 60) years was a component of a framework study of the transition from not having age-related macular degeneration to having early AMD. Drusen categories assessed using fundus photography and optical coherence tomography included small hard drusen (diameter < 63 μm), intermediate soft drusen (63–125 μm), and large soft drusen (> 125 μm), of which the soft drusen are compatible with a diagnosis of AMD.
Results
Having ≥ 20 small hard drusen within or outside the macula was associated with increasing age, lower body mass index, shorter axial length, hyperopia, female sex, increasing high-density lipoprotein (HDL), high alcohol consumption, and with the presence of soft drusen.
Conclusions
Having ≥ 20 small hard drusen was associated with some AMD-related risk factors, but not with smoking, increasing body mass index, and higher blood pressure. Having ≥ 20 small hard drusen was also associated with soft drusen, in agreement with previous studies. These findings suggest that small hard drusen are not an early manifestation of AMD but the product of a distinct process of tissue alteration that promotes the development of AMD or some subtype thereof.
Citation: Belmouhand M, Rothenbuehler SP, Dabbah S, Bjerager J, Sander B, Hjelmborg JB, et al. (2022) Small hard drusen and associated factors in early seniority. PLoS ONE 17(12): e0279279. https://doi.org/10.1371/journal.pone.0279279
Editor: Vikas Khetan, University of Rochester FEI: University of Rochester David and Ilene Flaum Eye Institute, UNITED STATES
Received: June 27, 2022; Accepted: December 2, 2022; Published: December 22, 2022
Copyright: © 2022 Belmouhand et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Data Availability: For previewing the dataset, please use the following URL: https://osf.io/ft5mr. Further enquiries can be directed to the corresponding author.
Funding: The study was supported by the Rigshospitalet (grant E-23334-02), P. Carl Petersens Fond (grant 19102), Helsefonden (grant 19-B-0063), Aase og Ejnar Danielsens Fond (grant 18-10-0698), Beckett Fonden (grant 19-2-3490) and Fabrikant Einar Willumsen Mindelegat (grant 500028). JB was supported by the Velux Foundations (grant 00028975). SB was supported, in part, by the OPOS Foundation. The funding organizations had no role in the design or conduct of this research.
Competing interests: The authors have declared that no competing interests exist.
Introduction
Small hard drusen are sharply demarcated bright elements located within or behind the retinal pigment epithelium. They typically have a diameter smaller than 63 μm [1–3]. Our study group showed in a recently published 20-year follow-up twin study that ≥ 20 small hard drusen is significantly associated with drusen ≥ 63 μm [4], which is the conventional threshold for diagnosing age-related macular degeneration (AMD). In the Watermen Study, the presence of numerous (≥ 5) small hard drusen was associated with a higher incidence of soft drusen ≥ 63 μm [5]. The association between small hard drusen and soft drusen ≥ 63 μm was confirmed by the Beaver Dam Eye Study [6]. It is unknown if small hard drusen are direct topographic precursors of soft drusen or if soft drusen develop independently of the exact location of small hard drusen. However, the empirical risk factors of small hard drusen are obviously of interest for the study of AMD.
The risk of having ≥ 20 small hard drusen per eye was previously examined in the Inter99 cohort [7]. It was associated with moderately elevated triglycerides and low serum high-density lipoprotein (HDL) in a study population with a median age lower than 50 years and relatively few cases with AMD.
Established risk factors for AMD include age [8], tobacco smoking [8], genetic predisposition [9,10], race [11], cardiovascular disease [Age-Related Eye Disease Study Research Group 12], relative hyperopia [13], shorter axial length [14], fatty foods [15,16] and a higher body mass index [17].
The present study aimed to examine risk factors for small hard drusen in comparison with known AMD-associated risk factors in a cohort of twins with a median age higher than 50 years.
Materials and methods
The observational Copenhagen Twin Cohort Eye Study includes pairs of twins from the Danish Twin Registry [18] in a balanced proportion of monozygotic and dizygotic pairs. The study is designed to examine the interaction between genes and environment in the development of eye and vision characteristics. A subgroup of the participants first underwent an eye examination in 1999 as part of a longitudinal cohort study (GEMINAKAR [19,20]). Additional participants with a comparable sex and zygosity distribution, but a wider age span, were recruited in 2019 from the Danish Twin Registry. Oral and written informed consent was obtained from the participants. Ethics Committee approval was obtained (registration number H-18052822) along with Danish Data Protection Agency approval (registration number VD-2018-434). The study adhered to the tenets of the Declaration of Helsinki.
The study included same-sex pairs of twins 30 years or older. The study excluded pairs of twins in whom one or both had an ocular disorder that interfered with retinal imaging. Participants were enrolled between March 1, 2019 and June 31, 2020.
Past medical history included all current and previous diseases, including non-ocular diseases, family history of eye diseases, contact lens use, current medication and allergies. The following parameters were recorded at the study visit: Sex, zygosity, ethnicity, height, weight, alcohol consumption, and smoking. Smoking was defined as active/history tobacco use if ≥ 1 pack-year (≥ 20 cigarettes daily for 365 consecutive days). Alcohol consumption was categorized as below or above 14 units/week for men or 7 units/week for women (1 unit = 12 g ethanol). Because few participants had hypertension, we used mean arterial pressure to assess the role of blood pressure. Quantification of smoking, alcohol consumption, height, and weight was self-reported. Because the number of participants who have diabetes was low, the assessment of glucose metabolism was based on glycated hemoglobin (HbA1c).
A blood sample was drawn from each participant and analyzed for glycated hemoglobin (HbA1c), triglycerides, low-density lipoprotein (LDL), high-density lipoprotein (HDL), very low-density lipoprotein (VLDL), and total cholesterol.
Participants underwent a complete ophthalmic examination including assessment of refraction and best-corrected visual acuity (BCVA) using Early Treatment Diabetic Retinopathy Study (ETDRS) charts at four meters, slit lamp examination, rebound tonometry, mydriatic fundus photography, spectral-domain optical coherence tomography (SD-OCT; Spectralis OCT 2, Heidelberg Engineering, Heidelberg, Germany) in the form of disc topography (25 disc-centered, radial b-scans and three circumpapillary scans in high resolution), and a macula volume scan (20x20 degree, 97 b-scans, high resolution and 20-scan averaging). Mydriatic color and red-free fundus photography (Topcon, TRC 50DX, Tokyo, Japan) included one color image (50° fovea-centered image) and four red-free images (one fovea-centered, one disc-centered, one superior arc-centered, and one inferior arc-centered).
Fundus images were assessed, graded, and annotated on a digital image platform (Fiji ImageJ v. 1.49 software) by a single observer (MB) masked to age, sex and zygosity. Drusen counts were made on red-free fundus images. Small hard drusen were defined as bright, sharply demarcated elements with a greatest linear diameter < 63 μm. Macular drusen seen on red-free fundus images were reviewed on color fundus images and OCT to help determine their size and category: Small hard drusen (< 63 μm), intermediate drusen (63–125 μm) or large drusen (> 125 μm). Drusen > 125 μm were subcategorized into the following types as seen by OCT: Soft drusen, pachydrusen, and reticular drusen. Cuticular drusen were not observed. Intermediate drusen (63–125 μm) were not reliably classifiable in this system and were regarded as separate entities. Attention was given to avoid confusing drusen-like bright elements with other retinal diseases or conditions, such as hard exudate. Small hard drusen counts (average of the two eyes) were classified as no small hard drusen, 1 to 19 small hard drusen per eye, and 20 or more small hard macular drusen per eye for a macular field defined by a circle centered in the fovea and extending to the temporal edge of the optic nerve head, or 20 or more small hard extramacular drusen per eye for the area outside this circle (Fig 1) [21].
Red-free fundus photograph of a healthy eye with numerous small hard drusen inside and outside a macular annotation field marked by a red circle.
Drusen outside the circle were classified as extramacular drusen. The determination of the number of drusen may be unreliable when over 20 drusen per eye are counted [22]. Therefore, we used ≥ 20 as the threshold for defining numerous small hard drusen. The average number of small hard drusen of a participant’s two eyes was used in all analyses and rounded up to the nearest integer. Analyses of right eyes only and left eyes only gave comparable results. Arbitration of cases, when relevant, was made when relevant by another observer (ML).
Choroidal thickness by SD-OCT was made by manual marking using a dedicated software tool (Heidelberg Eye Explorer, version 1.10.4.0, Heidelberg Engineering, Germany) on a horizontal transfoveal line scan at the center of the fovea and 1 mm temporal of the foveal center.
Statistical methods
Data analysis was performed using RStudio (Integrated Development Environment for R, Inc., Boston, MA). Appropriate statistical methods were used to correct for paired samples and to calculate outcomes that can be compared with those found in singletons. Comparison of men and women was achieved with a chi-square test for categorical variables and a linear mixed model with fixed effects for continuous variables. The mixed model with fixed effects approach was used to keep various variable estimates constant within twin pairs. Associations between ≥ 20 small hard drusen per eye and potential associations–a priori chosen based on available evidence in the literature–were initially analyzed using a univariate logistical regression model with robust clustered standard errors adjusted for age, sex, and clustering (within pairs of twins). Estimates from the logistical regression model are shown as odds ratio (OR) and 95% confidence interval (CI95). For a matched co-twin multivariable analysis, a conditional logistic regression model was used with the same parameters included in the univariate analyses to allow for a more precise estimate of effect measure. Clopper-Pearson confidence interval for a binomial proportion was used for proportional estimates. Age was defined in years and entered as a continuous or ordinal variable (< 49, 50–65, and > 65 years). Estimates of choroidal thickness, spherical equivalent and axial length were comparable for right and left eyes, and this report included an average of both eyes in the regression analyses, respectively. A p-value < 0.05, two-sided, was considered significant.
Results
The study enrolled 352 participants from 91 monozygotic same-sex twin pairs and 85 dizygotic same-sex twin pairs (Table 1). Five participants were excluded from analysis because the quality of their fundus photographs was insufficient for grading, which left 347 participants for analysis (Table 1). Participant age ranged from 30 to 80 years. All were born in Denmark, and one resided abroad at the time of examination. Examinations were made at the Rigshospitalet.
Small hard macular drusen were found in 271 right eyes (78.1% [CI95 73.4% - 82.3%]) and 254 left eyes (73.1% [CI95 68.2% - 77.8%]). One or more small hard macular drusen in either eye were found in 305 participants (87.9% [CI95 84.0% - 91.1%]). The distribution was comparable in men and women (p = 0.14, chi-square test). Recounts of small hard macular drusen showed an intraclass correlation coefficient for conformity among the counts vs. recounts of 0.98 [CI95 0.98–0.99], p < 0.001, for right eyes with identical numbers for left eyes.
The characteristic ≥ 20 small hard macular drusen per eye was found in 43 (12.4%) participants, and the phenotype ≥ 20 small hard extramacular drusen per eye was found in 96 (27.7%). The characteristic ≥ 20 small hard macular drusen per eye combined with ≥ 20 small hard extramacular drusen per eye was found in 33 (9.5% of the total study population). Intermediate drusen were found in 20 (5.8%) participants, large drusen were found in 29 (8.4%), and only two participants had late-stage AMD.
The proportion of participants with 1–19 drusen per eye decreased with each increase in age bracket in proportion to a concomitant rise in the proportions of participants with ≥ 20 small hard macular drusen and participants with drusen ≥ 63 μm (Table 2, Fig 2). This trajectory did not differ between men and women.
Cumulative frequency of having ≥ 20 small hard macular drusen per eye as a function of age and sex.
In the univariate analyses, the odds of having ≥ 20 hard macular drusen per eye increased significantly with age (p = 0.04, Table 3). A trend was seen for a higher prevalence of ≥ 20 hard macular drusen per eye and lower body mass index (BMI). In a univariate analysis, the trait ≥ 20 small hard extramacular drusen per eye was associated with increasing age, female sex, lower BMI, shorter axial length, and a thicker choroidal (Table 3).
In multivariable analysis (Table 4), the odds of having ≥ 20 small hard macular drusen per eye also increased with age, lower BMI, and shorter axial length. The odds of having ≥ 20 small hard extramacular drusen increased with age, female sex, lower BMI, high alcohol consumption, high HDL, hyperopia, and shorter axial length (Table 4). The effect of a thicker choroid disappeared when the parameter was analyzed in conjunction with axial length and spherical equivalent refraction.
Large drusen (> 125 μm) were associated with ≥ 20 small hard macular drusen per eye (p = 0.02, chi-square test) but not with ≥ 20 small hard extramacular drusen per eye (Table 5).
The median number of small hard macular drusen was 9 (interquartile range [IQR] = 4–24) in participants with large drusen and 3 (IQR = 1–8) in participants without large drusen (p = 0.008).
The median number of small hard extramacular drusen was 15 (IQR = 6–56) in participants with large drusen and 6 (IQR = 2–21) in participants without large drusen (p = 0.24).
Discussion
This study of small hard drusen in people in the early years of AMD age range found that 12.4% of participants had the prominent characteristic of having ≥ 20 small hard macular drusen per eye. Small hard drusen are not a part of the AMD fundus lesion spectrum, as it is currently defined, but the trait was found to share certain risk factors with AMD, including higher age, shorter axial length, and hyperopia. An effect of a thicker choroid sank below the level of statistical significance after correction of refraction and axial length. However, the three factors are closely correlated, with the choroidal thickness being the factor that is by far the most difficult to measure, suggesting that length and refraction may be surrogate measures of a mechanistic factor that resides in the choroid.
Small hard drusen were correlated with the presence of large drusen, i.e., drusen with a diameter greater than 125 μm. Because no large drusen were found in 1999, when one-half of the participants were seen, the most obvious interpretation is that ≥ 20 small hard macular drusen per eye are a risk factor for developing large drusen, as previously shown [5,6].
The Watermen Study showed that five or more small hard drusen were associated with an increased 5-year incidence of large drusen [5]. The Beaver Dam Eye Study showed that the larger the posterior pole area covered with small hard drusen at baseline, the higher the 15-year cumulative incidence of early AMD [6]. The progression from small hard drusen to the larger drusen compatible with the diagnosis of AMD in the aforementioned studies was based on eye-by-eye grading, not in situ lesion-by-lesion comparisons. Thus, small hard drusen can be seen to disappear [1], but the direct progression from small hard drusen to large drusen in the same location has only recently been explored by our study group with our twin cohort in a 20-year follow-up study. We identified three participants where large drusen had developed in a place previously occupied by small hard drusen. Also, having ≥ 20 small hard drusen at baseline increased the 20-year risk of developing larger drusen [4].
Clinicopathological correlation between small hard drusen in vivo and in histopathology sections has been made on a small scale [1,2]. These findings suggest that small hard drusen may be part of a continuum encompassing drusen ≥ 63 μm and hence fit the diagnosis of AMD.
If small hard drusen are indeed precursors or heralds of larger soft drusen, one would assume similar risk profiles in terms of modifiable and non-modifiable risk factors between the two phenotypes, which was not the case in this study. This raises the suspicion that small hard drusen may be a selective precursor for some but not all types of drusen compatible with the diagnosis of AMD.
The close resemblance of the risk factors for small hard drusen inside and outside the macula warrants consideration of whether the two can be merged in natural history studies. The larger total drusen numbers would help justify their treatment as a continuous variable in statistical analyses.
This study found that longer axial lengths decreased the odds of having ≥ 20 small hard macular or ≥ 20 small hard extramacular drusen. This agrees with studies that found a higher incidence of AMD in shorter eyes (axial length < 23 mm) [14,23]. A shorter axial length is strongly associated with a thicker choroid [24] and hyperopia, all of which were associated with ≥ 20 small hard extramacular drusen in the present study and, in another study, with a higher risk of incident AMD [13]. In the AREDS cohort, the authors also found an association between hyperopia and late AMD [25]. The close correlation between axial length, refraction, and choroidal thickness may explain why no independent effect was found of the latter in the present study (Table 4). Thus, the Copenhagen Child Cohort 2000 Study of healthy children found that a thicker choroid was associated with higher odds of having small hard drusen [26]. A thicker choroid is associated with pachydrusen [27]. Theoretically, stretching of Bruch’s membrane in myopia may increase its pore size, reduce its thickness, and promote increased flux through the membrane, thus reducing the formation of drusen.
Higher HDL and female sex were associated with ≥ 20 extramacular drusen. Similar results were found in a large review examining AMD risk factors, although some of the included studies found no associations between higher HDL or female sex and increased AMD risk [28].
Higher body mass index was associated with lower odds for having ≥ 20 small hard macular and extramacular drusen, which is in contrast to AMD, where excess body weight was associated, in a dose-dependent, with AMD [29]. Furthermore, alcohol overconsumption was associated with having ≥ 20 small hard extramacular drusen. In contrast, a systematic review and meta-analysis found no relationship between alcohol intake and AMD [30].
Smoking is of particular interest among the factors known to influence AMD that had no measurable effect on small hard drusen in this study. Smoking is a strong promotor of AMD [31]. The lack of association with small hard drusen confirms our previous finding in the Inter99 Eye Study [21]. Also, higher arterial blood pressure was not associated with ≥ 20 small hard drusen, macular or extramacular, unlike AMD, which is associated with hypertension [25]. However, a limitation regarding hypertension in the present study should be noted, namely that we used mean arterial pressure as the descriptive variable for blood pressure.
The study cohort covered an age spectrum that suits the study of early AMD. Thus, only two participants had late AMD. The number of participants with ≥ 20 small hard drusen per eye (macular, n = 43 and extramacular, n = 96) was sufficient, however, to identify a risk factor profile for small hard drusen. It was found to differ significantly from that of AMD. Thus, the study provides new information about a stage in the transition from not having AMD to having AMD and highlights the role of potential precursor lesions for drusen compatible with the diagnosis of AMD. Limitations of the study includes the reliance on self-reporting of body weight, tobacco, and alcohol consumption, which entails the risk of recency and recall bias. Although we adjusted for dependencies between twins, there are both data limitations and imperfections of statistical models. Finally, genotypes, dietary habits, and physical activity were not examined or acquired.
In conclusion, we observed that certain AMD-associated risk factors were associated with the presence of ≥ 20 small hard macular drusen: increasing age, shorter axial length, hyperopia, and female sex. Unlike AMD, having ≥ 20 small hard macular drusen was not associated with alcohol consumption, smoking, higher blood pressure, and dyslipidemia. The study results may help advance the study of drusen formation and drusen subtypes and assist the development of early interventions against AMD.
References
- 1. Sarks SH, Arnold JJ, Killingsworth MC, Sarks JP. Early drusen formation in the normal and aging eye and their relation to age related maculopathy: a clinicopathological study. Br J Ophthalmol. 1999;83(3):358–68. pmid:10365048
- 2. Sarks JP, Sarks SH, Killingsworth MC. Evolution of soft drusen in age-related macular degeneration. Eye (Lond). 1994;8 (Pt 3):269–83. pmid:7525362
- 3. Rudolf M, Clark ME, Chimento MF, Li CM, Medeiros NE, Curcio CA. Prevalence and morphology of druse types in the macula and periphery of eyes with age-related maculopathy. Invest Ophthalmol Vis Sci. 2008;49(3):1200–9. pmid:18326750
- 4. Belmouhand M, Rothenbuehler SP, Bjerager J, Dabbah S, Hjelmborg JB, Munch IC, et al. Heritability and risk factors of incident small and large drusen in the Copenhagen Twin Cohort Eye Study: a 20-year follow-up. Ophthalmologica. 2022; pmid:35878587
- 5. Bressler NM, Munoz B, Maguire MG, Vitale SE, Schein OD, Taylor HR, et al. Five-year incidence and disappearance of drusen and retinal pigment epithelial abnormalities. Waterman study. Arch Ophthalmol. 1995;113(3):301–8. pmid:7534060
- 6. Klein R, Myers CE, Lee KE, Gangnon RE, Sivakumaran TA, Iyengar SK, et al. Small Drusen and Age-Related Macular Degeneration: The Beaver Dam Eye Study. J Clin Med. 2015;4(3):424–40. pmid:25905023
- 7. Munch IC, Linneberg A, Larsen M. Precursors of age-related macular degeneration: associations with physical activity, obesity, and serum lipids in the inter99 eye study. Invest Ophthalmol Vis Sci. 2013;54(6):3932–40. pmid:23652489
- 8. Smith W, Assink J, Klein R, Mitchell P, Klaver CC, Klein BE, et al. Risk factors for age-related macular degeneration: Pooled findings from three continents. Ophthalmology. 2001;108(4):697–704. pmid:11297486
- 9. Hageman GS, Anderson DH, Johnson LV, Hancox LS, Taiber AJ, Hardisty LI, et al. A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. Proc Natl Acad Sci U S A. 2005;102(20):7227–32. pmid:15870199
- 10. Yu Y, Reynolds R, Rosner B, Daly MJ, Seddon JM. Prospective assessment of genetic effects on progression to different stages of age-related macular degeneration using multistate Markov models. Invest Ophthalmol Vis Sci. 2012;53(3):1548–56. pmid:22247473
- 11. Klein R, Klein BE, Knudtson MD, Wong TY, Cotch MF, Liu K, et al. Prevalence of age-related macular degeneration in 4 racial/ethnic groups in the multi-ethnic study of atherosclerosis. Ophthalmology. 2006;113(3):373–80. pmid:16513455
- 12. Risk factors associated with age-related macular degeneration. A case-control study in the age-related eye disease study: Age-Related Eye Disease Study Report Number 3. Ophthalmology. 2000;107(12):2224–32. pmid:11097601
- 13. Pan CW, Ikram MK, Cheung CY, Choi HW, Cheung CM, Jonas JB, et al. Refractive errors and age-related macular degeneration: a systematic review and meta-analysis. Ophthalmology. 2013;120(10):2058–65. pmid:23706699
- 14. Lavanya R, Kawasaki R, Tay WT, Cheung GC, Mitchell P, Saw SM, et al. Hyperopic refractive error and shorter axial length are associated with age-related macular degeneration: the Singapore Malay Eye Study. Invest Ophthalmol Vis Sci. 2010;51(12):6247–52. pmid:20671287
- 15. Seddon JM, Cote J, Rosner B. Progression of age-related macular degeneration: association with dietary fat, transunsaturated fat, nuts, and fish intake. Arch Ophthalmol. 2003;121(12):1728–37. pmid:14662593
- 16. Merle BM, Silver RE, Rosner B, Seddon JM. Adherence to a Mediterranean diet, genetic susceptibility, and progression to advanced macular degeneration: a prospective cohort study. Am J Clin Nutr. 2015;102(5):1196–206. pmid:26490493
- 17. Seddon JM, Cote J, Davis N, Rosner B. Progression of age-related macular degeneration: association with body mass index, waist circumference, and waist-hip ratio. Arch Ophthalmol. 2003;121(6):785–92. pmid:12796248
- 18. Pedersen DA, Larsen LA, Nygaard M, Mengel-From J, McGue M, Dalgård C, et al. The Danish Twin Registry: An Updated Overview. Twin Res Hum Genet. 2019;22(6):499–507. pmid:31544734
- 19. Schousboe K, Visscher PM, Henriksen JE, Hopper JL, Sørensen TI, Kyvik KO. Twin study of genetic and environmental influences on glucose tolerance and indices of insulin sensitivity and secretion. Diabetologia. 2003;46(9):1276–83. pmid:12898014
- 20. Munch IC, Sander B, Kessel L, Hougaard JL, Taarnhøj NC, Sørensen TI, et al. Heredity of small hard drusen in twins aged 20–46 years. Invest Ophthalmol Vis Sci. 2007;48(2):833–8. pmid:17251485
- 21. Munch IC, Linneberg A, Larsen M. Precursors of Age-Related Macular Degeneration: Associations With Physical Activity, Obesity, and Serum Lipids in the Inter99 Eye Study. Invest Ophthalmol Vis Sci. 2013;54(6):3932–40. pmid:23652489
- 22. Bressler SB, Bressler NM, Seddon JM, Gragoudas ES, Jacobson LP. Interobserver and intraobserver reliability in the clinical classification of drusen. Retina. 1988;8(2):102–8. pmid:3420310
- 23. Gürbüz Yurtseven Ö, Aksoy S, Karatay Arsan A, Buyru Özkurt Y, Kökçen HK. Evaluation of the Relationship Between Age-related Macular Degeneration and Refractive Error, Socio-demographic Features, and Biochemical Variables in a Turkish Population. Turk J Ophthalmol. 2018;48(5):238–44. pmid:30405945
- 24. Li XQ, Larsen M, Munch IC. Subfoveal choroidal thickness in relation to sex and axial length in 93 Danish university students. Invest Ophthalmol Vis Sci. 2011;52(11):8438–41. pmid:21917938
- 25. Group AR. Risk factors associated with age-related macular degeneration. A case-control study in the age-related eye disease study: Age-Related Eye Disease Study Report Number 3. Ophthalmology. 2000;107(12):2224–32. pmid:11097601
- 26. Munch IC, Li XQ, Ahmad SSM, Olsen EM, Skovgaard AM, Larsen M. Small Hard Macular Drusen and Associations in 11- to 12-Year-Old Children in the Copenhagen Child Cohort 2000 Eye Study. Invest Ophthalmol Vis Sci. 2019;60(5):1454–60. pmid:30947335
- 27. Cheung CMG, Gan A, Yanagi Y, Wong TY, Spaide R. Association between Choroidal Thickness and Drusen Subtypes in Age-Related Macular Degeneration. Ophthalmol Retina. 2018;2(12):1196–205. pmid:31047191
- 28. Heesterbeek TJ, Lorés-Motta L, Hoyng CB, Lechanteur YTE, den Hollander AI. Risk factors for progression of age-related macular degeneration. Ophthalmic Physiol Opt. 2020;40(2):140–70. pmid:32100327
- 29. Zhang QY, Tie LJ, Wu SS, Lv PL, Huang HW, Wang WQ, et al. Overweight, Obesity, and Risk of Age-Related Macular Degeneration. Invest Ophthalmol Vis Sci. 2016;57(3):1276–83. pmid:26990164
- 30. Chong EW, Kreis AJ, Wong TY, Simpson JA, Guymer RH. Alcohol consumption and the risk of age-related macular degeneration: a systematic review and meta-analysis. Am J Ophthalmol. 2008;145(4):707–15. pmid:18242575
- 31. Velilla S, García-Medina JJ, García-Layana A, Dolz-Marco R, Pons-Vázquez S, Pinazo-Durán MD, et al. Smoking and age-related macular degeneration: review and update. J Ophthalmol. 2013;2013:895147. pmid:24368940